Product Description

Jakavi Tablets 15mg contains Ruxolitinib, a Janus kinase (JAK) inhibitor indicated for the treatment of myelofibrosis, polycythemia vera, and steroid-refractory graft-versus-host disease.

Product Overview

Product Name: Jakavi Tablets 15mg

Generic Name: Ruxolitinib

Strength: 15mg

Form: Tablets

Pack Size: As per manufacturer packaging

Used For: Treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease

Prescription Required: Yes

Ingredients & How They Work

Each tablet contains Ruxolitinib 15mg, which blocks JAK1 and JAK2 enzymes to reduce abnormal blood cell production and inflammatory signaling.

Key Benefits

• Helps control myelofibrosis symptoms
• Treats polycythemia vera
• Used in graft-versus-host disease
• Reduces spleen enlargement
• Convenient oral therapy

How to Use

Take exactly as directed by your healthcare provider. The dosage depends on your blood counts and medical condition.

Side Effects & Precautions

Possible Side Effects

• Anemia
• Low platelet count
• Dizziness
• Headache
• Increased infection risk

Precautions

• Regular blood tests are required.
• Report signs of infection immediately.
• Avoid live vaccines unless advised by your doctor.
• Follow all scheduled medical appointments.

Storage Instructions

Store below 30°C in a cool, dry place away from heat and moisture.